Patrick A. Marcotte

3.8k total citations
67 papers, 2.6k citations indexed

About

Patrick A. Marcotte is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Patrick A. Marcotte has authored 67 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 28 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Patrick A. Marcotte's work include Peptidase Inhibition and Analysis (17 papers), Protease and Inhibitor Mechanisms (14 papers) and Amino Acid Enzymes and Metabolism (8 papers). Patrick A. Marcotte is often cited by papers focused on Peptidase Inhibition and Analysis (17 papers), Protease and Inhibitor Mechanisms (14 papers) and Amino Acid Enzymes and Metabolism (8 papers). Patrick A. Marcotte collaborates with scholars based in United States, United Kingdom and Canada. Patrick A. Marcotte's co-authors include Christopher T. Walsh, Cecil H. Robinson, Steven K. Davidsen, Keith B. Glaser, Lori J. Pease, Michael L. Curtin, Jennifer J. Bouska, Jack Henkin, Michael R. Michaelides and Robin R. Frey and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Patrick A. Marcotte

66 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick A. Marcotte United States 33 1.5k 784 529 335 281 67 2.6k
Yafeng Xue Sweden 30 1.6k 1.1× 605 0.8× 253 0.5× 219 0.7× 103 0.4× 51 2.5k
Jacqueline Plowman United States 27 1.8k 1.2× 797 1.0× 682 1.3× 287 0.9× 77 0.3× 66 2.9k
Jonathan M. Elkins United Kingdom 30 2.8k 1.9× 497 0.6× 672 1.3× 827 2.5× 329 1.2× 73 4.0k
Michel Vidal France 31 1.6k 1.1× 571 0.7× 897 1.7× 249 0.7× 73 0.3× 182 3.3k
Frank Friedlos United Kingdom 30 2.2k 1.5× 688 0.9× 942 1.8× 266 0.8× 602 2.1× 59 3.2k
Anne M. Hassell United States 21 1.6k 1.1× 585 0.7× 1.0k 1.9× 408 1.2× 107 0.4× 32 2.9k
Sidney D. Lewis United States 31 1.2k 0.8× 539 0.7× 364 0.7× 233 0.7× 126 0.4× 71 2.5k
Lawrence G. Hamann United States 32 1.8k 1.2× 1.3k 1.6× 498 0.9× 97 0.3× 423 1.5× 64 4.2k
Peter L. Toogood United States 27 1.6k 1.1× 752 1.0× 1.5k 2.7× 260 0.8× 89 0.3× 55 3.6k
Allan Wissner United States 26 1.9k 1.3× 1.5k 1.9× 1.9k 3.6× 237 0.7× 154 0.5× 64 4.2k

Countries citing papers authored by Patrick A. Marcotte

Since Specialization
Citations

This map shows the geographic impact of Patrick A. Marcotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick A. Marcotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick A. Marcotte more than expected).

Fields of papers citing papers by Patrick A. Marcotte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick A. Marcotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick A. Marcotte. The network helps show where Patrick A. Marcotte may publish in the future.

Co-authorship network of co-authors of Patrick A. Marcotte

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick A. Marcotte. A scholar is included among the top collaborators of Patrick A. Marcotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick A. Marcotte. Patrick A. Marcotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allard, Jacques, et al.. (2014). Impact of an Oral Theophylline Loading Dose Pre-Electroconvulsive Therapy. Journal of Ect. 31(1). 37–42. 10 indexed citations
2.
Curtin, Michael L., Robin R. Frey, H. Robin Heyman, et al.. (2012). Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families. Bioorganic & Medicinal Chemistry Letters. 22(9). 3208–3212. 19 indexed citations
3.
Curtin, Michael L., H. Robin Heyman, Robin R. Frey, et al.. (2012). Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases. Bioorganic & Medicinal Chemistry Letters. 22(14). 4750–4755. 12 indexed citations
4.
Ji, Zhiqin, Yujia Dai, Cele Abad‐Zapatero, et al.. (2012). Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(14). 4528–4531. 5 indexed citations
5.
Dai, Yujia, Niru B. Soni, Lori J. Pease, et al.. (2007). Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 386–390. 31 indexed citations
6.
Heyman, H. Robin, Robin R. Frey, Peter F. Bousquet, et al.. (2006). Thienopyridine urea inhibitors of KDR kinase. Bioorganic & Medicinal Chemistry Letters. 17(5). 1246–1249. 33 indexed citations
7.
Sun, Chaohong, Danying Song, Patrick A. Marcotte, Paul L. Richardson, & Philip J. Hajduk. (2006). High-level bacterial expression and purification of human SirT2 protein for NMR studies. Protein Expression and Purification. 48(1). 56–60. 2 indexed citations
8.
Glaser, Keith B., Lori J. Pease, Michael J. Staver, et al.. (2004). Differential protein acetylation induced by novel histone deacetylase inhibitors. Biochemical and Biophysical Research Communications. 325(3). 683–690. 51 indexed citations
9.
Sabet, Razieh, Patrick A. Marcotte, Keith B. Glaser, et al.. (2004). Screening for Inhibitors of Histone Deacetylase by Incorporating a Spraying Method to Micro-Arrayed Compound Screening. Combinatorial Chemistry & High Throughput Screening. 7(2). 93–100. 1 indexed citations
10.
Curtin, Michael L., Robert B. Garland, H. Robin Heyman, et al.. (2002). Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC). Bioorganic & Medicinal Chemistry Letters. 12(20). 2919–2923. 97 indexed citations
11.
Frey, Robin R., Carol K. Wada, Robert B. Garland, et al.. (2002). Trifluoromethyl ketones as inhibitors of histone deacetylase. Bioorganic & Medicinal Chemistry Letters. 12(23). 3443–3447. 116 indexed citations
12.
Holms, James H., Patrick A. Marcotte, Junling Li, et al.. (2001). Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-α converting enzyme. Bioorganic & Medicinal Chemistry Letters. 11(22). 2907–2910. 41 indexed citations
13.
Dellaria, Joseph F., James H. Holms, Jennifer J. Bouska, et al.. (2001). Biaryl Ether Retrohydroxamates as Potent, Long-lived, Orally Bioavailable MMP Inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(12). 1553–1556. 43 indexed citations
14.
Marcotte, Patrick A., Zhiwen Guan, Terrance J. Magoc, et al.. (1999). Evaluation of the Inhibition of other Metalloproteinases by Matrix Metalloproteinase Inhibitors. Journal of enzyme inhibition. 14(6). 425–435. 6 indexed citations
15.
Steinman, Douglas H., Michael L. Curtin, Robert B. Garland, et al.. (1998). The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(16). 2087–2092. 26 indexed citations
16.
Henkin, Jack, et al.. (1991). The plasminogen-plasmin system. Progress in Cardiovascular Diseases. 34(2). 135–164. 63 indexed citations
17.
Plattner, Jacob J., Patrick A. Marcotte, Hollis D. Kleinert, et al.. (1988). Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability. Journal of Medicinal Chemistry. 31(12). 2277–2288. 54 indexed citations
18.
Luly, Jay R., Nwe Y. BaMaung, Anthony K. L. Fung, et al.. (1988). Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency. Journal of Medicinal Chemistry. 31(12). 2264–2276. 53 indexed citations
19.
Sham, Hing L., Giorgio Bolis, Herman H. Stein, et al.. (1988). Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogs of angiotensinogen. Journal of Medicinal Chemistry. 31(2). 284–295. 36 indexed citations
20.
Bolis, Giorgio, Anthony K. L. Fung, Jonathan Greer, et al.. (1987). Renin inhibitors. Dipeptide analogs of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond. Journal of Medicinal Chemistry. 30(10). 1729–1737. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yafeng Xue Breakdown of academic impact, for papers by Jacqueline Plowman Breakdown of academic impact, for papers by Jonathan M. Elkins Breakdown of academic impact, for papers by Michel Vidal Breakdown of academic impact, for papers by Frank Friedlos Breakdown of academic impact, for papers by Anne M. Hassell Breakdown of academic impact, for papers by Sidney D. Lewis Breakdown of academic impact, for papers by Lawrence G. Hamann Breakdown of academic impact, for papers by Peter L. Toogood Breakdown of academic impact, for papers by Allan Wissner
Rankless by CCL
2026